370 related articles for article (PubMed ID: 26704351)
1. Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia.
Galea CA; Huq A; Lockhart PJ; Tai G; Corben LA; Yiu EM; Gurrin LC; Lynch DR; Gelbard S; Durr A; Pousset F; Parkinson M; Labrum R; Giunti P; Perlman SL; Delatycki MB; Evans-Galea MV
Ann Neurol; 2016 Mar; 79(3):485-95. PubMed ID: 26704351
[TBL] [Abstract][Full Text] [Related]
2. Frataxin gene point mutations in Italian Friedreich ataxia patients.
Gellera C; Castellotti B; Mariotti C; Mineri R; Seveso V; Didonato S; Taroni F
Neurogenetics; 2007 Nov; 8(4):289-99. PubMed ID: 17703324
[TBL] [Abstract][Full Text] [Related]
3. A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype.
Evans-Galea MV; Corben LA; Hasell J; Galea CA; Fahey MC; du Sart D; Delatycki MB
Neurogenetics; 2011 Nov; 12(4):307-13. PubMed ID: 21830088
[TBL] [Abstract][Full Text] [Related]
4. Exonic deletions of FXN and early-onset Friedreich ataxia.
Anheim M; Mariani LL; Calvas P; Cheuret E; Zagnoli F; Odent S; Seguela C; Marelli C; Fritsch M; Delaunoy JP; Brice A; Dürr A; Koenig M
Arch Neurol; 2012 Jul; 69(7):912-6. PubMed ID: 22409940
[TBL] [Abstract][Full Text] [Related]
5. Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.
Evans-Galea MV; Lockhart PJ; Galea CA; Hannan AJ; Delatycki MB
Discov Med; 2014 Jan; 17(91):25-35. PubMed ID: 24411698
[TBL] [Abstract][Full Text] [Related]
6. FXN methylation predicts expression and clinical outcome in Friedreich ataxia.
Evans-Galea MV; Carrodus N; Rowley SM; Corben LA; Tai G; Saffery R; Galati JC; Wong NC; Craig JM; Lynch DR; Regner SR; Brocht AF; Perlman SL; Bushara KO; Gomez CM; Wilmot GR; Li L; Varley E; Delatycki MB; Sarsero JP
Ann Neurol; 2012 Apr; 71(4):487-97. PubMed ID: 22522441
[TBL] [Abstract][Full Text] [Related]
7. Complete FXN deletion in a patient with Friedreich's ataxia.
van den Ouweland AM; van Minkelen R; Bolman GM; Wouters CH; Becht-Noordermeer C; Deelen WH; Deelen-Manders JM; Ippel EP; Saris J; Halley DJ
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1015-8. PubMed ID: 22691228
[TBL] [Abstract][Full Text] [Related]
8. Friedreich's ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion.
Zhu D; Burke C; Leslie A; Nicholson GA
Mov Disord; 2002 May; 17(3):585-9. PubMed ID: 12112211
[TBL] [Abstract][Full Text] [Related]
9. Genotype and phenotype analysis of Friedreich's ataxia compound heterozygous patients.
De Castro M; García-Planells J; Monrós E; Cañizares J; Vázquez-Manrique R; Vílchez JJ; Urtasun M; Lucas M; Navarro G; Izquierdo G; Moltó MD; Palau F
Hum Genet; 2000 Jan; 106(1):86-92. PubMed ID: 10982187
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients.
Castaldo I; Pinelli M; Monticelli A; Acquaviva F; Giacchetti M; Filla A; Sacchetti S; Keller S; Avvedimento VE; Chiariotti L; Cocozza S
J Med Genet; 2008 Dec; 45(12):808-12. PubMed ID: 18697824
[TBL] [Abstract][Full Text] [Related]
11. A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design.
Saccà F; Puorro G; Antenora A; Marsili A; Denaro A; Piro R; Sorrentino P; Pane C; Tessa A; Brescia Morra V; Cocozza S; De Michele G; Santorelli FM; Filla A
PLoS One; 2011 Mar; 6(3):e17627. PubMed ID: 21412413
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.
Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS
Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831
[TBL] [Abstract][Full Text] [Related]
13. Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.
Li H; Gakh O; Smith DY; Ranatunga WK; Isaya G
J Biol Chem; 2013 Feb; 288(6):4116-27. PubMed ID: 23269675
[TBL] [Abstract][Full Text] [Related]
14. Compound heterozygosity for an expanded (GAA) and a (GAAGGA) repeat at FXN locus: from a diagnostic pitfall to potential clues to the pathogenesis of Friedreich ataxia.
Santoro M; Perna A; La Rosa P; Petrillo S; Piemonte F; Rossi S; Riso V; Nicoletti TF; Modoni A; Pomponi MG; Chiurazzi P; Silvestri G
Neurogenetics; 2020 Oct; 21(4):279-287. PubMed ID: 32638185
[TBL] [Abstract][Full Text] [Related]
15. Heart and Nervous System Pathology in Compound Heterozygous Friedreich Ataxia.
Becker AB; Qian J; Gelman BB; Yang M; Bauer P; Koeppen AH
J Neuropathol Exp Neurol; 2017 Aug; 76(8):665-675. PubMed ID: 28789479
[TBL] [Abstract][Full Text] [Related]
16. Friedreich ataxia is not only a GAA repeats expansion disorder: implications for molecular testing and counselling.
Hoffman-Zacharska D; Mazurczak T; Zajkowski T; Tataj R; Górka-Skoczylas P; Połatyńska K; Kępczyński Ł; Stasiołek M; Bal J
J Appl Genet; 2016 Aug; 57(3):349-55. PubMed ID: 26906906
[TBL] [Abstract][Full Text] [Related]
17. HFE p.C282Y heterozygosity is associated with earlier disease onset in Friedreich ataxia.
Delatycki MB; Tai G; Corben L; Yiu EM; Evans-Galea MV; Stephenson SE; Gurrin L; Allen KJ; Lynch D; Lockhart PJ
Mov Disord; 2014 Jun; 29(7):940-3. PubMed ID: 24390816
[TBL] [Abstract][Full Text] [Related]
18. Friedreich ataxia: Detection of GAA repeat expansions and frataxin point mutations.
Pandolfo M
Methods Mol Med; 2006; 126():197-216. PubMed ID: 16930014
[TBL] [Abstract][Full Text] [Related]
19. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.
Al-Mahdawi S; Pinto RM; Varshney D; Lawrence L; Lowrie MB; Hughes S; Webster Z; Blake J; Cooper JM; King R; Pook MA
Genomics; 2006 Nov; 88(5):580-90. PubMed ID: 16919418
[TBL] [Abstract][Full Text] [Related]
20. Somatic instability of the expanded GAA repeats in Friedreich's ataxia.
Long A; Napierala JS; Polak U; Hauser L; Koeppen AH; Lynch DR; Napierala M
PLoS One; 2017; 12(12):e0189990. PubMed ID: 29261783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
